Navigation Links
Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
Date:5/28/2008

SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst and investor briefing event "Sequenom: The Future of Noninvasive Prenatal Diagnostics." Details of the event are as follows:

What: Sequenom: The Future of Noninvasive Prenatal Diagnostics

When: Tuesday, June 3, 2008 at 6:00 p.m. Pacific time

Where: http://www.sequenom.com

Agenda:

Hosted by:

Harry Stylli, Ph.D., Chief Executive Officer of Sequenom, Inc.

Presenters:

Jacob Canick, Ph.D., Professor of Pathology and Laboratory Medicine

Brown University Medical School

"Methods for screening pregnancies for Down syndrome"

Allan T. Bombard, MD, FACOG, FACS, FACMG, Chief Medical Officer, Sharp

Mary Birch Hospital; Adjunct Professor, Obstetrics and Gynecology/SUNY

Downstate Medical Center; Clinical Professor, Albert Einstein College of

Medicine

"Current clinical practice for Down syndrome screening and diagnosis"

Betty Dragon, Ph.D., Senior Vice President, Research & Development of

Sequenom, Inc.

"Sequenom's SEQureDx: A noninvasive prenatal diagnostic test for Down

syndrome. Technical Achievements, Milestones and Future Challenges"

Dennis Lo, Consultant to Sequenom, Inc.

"The future of prenatal diagnosis: Progress through fetal nucleic acids"

How: Live over the Internet - Simply log on to the web at the address

above. Presentation will be archived.

Contact: Lippert/Heilshorn & Associates

Jody Cain (jcain@lhai.com)

310-691-7100

About Sequenom

Sequenom is committed to providing the best genetic analysis products for research and the molecular diagnostic markets. The Company makes available superior solutions for genomic science in biomedical research, livestock and agricultural applications and molecular medicine, as well as for various diagnostic markets, including noninvasive prenatal testing, oncology and infectious diseases. Sequenom's proprietary MassARRAY(R) system delivers reliable and specific data from complex biological samples and from genetic target materials available only in trace amounts.

Minimum Requirements to listen to broadcast:

The Windows Media Player software, downloadable free from http://www.microsoft.com and at least a 56Kbps connection to the Internet. If you experience problems listening to the webcast, send an E-mail to: webcast@multivu.com.


'/>"/>
SOURCE Sequenom, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
2. REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO
3. Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing
4. CorVel Corporation Announces Earnings Release Webcast
5. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
6. Vasogen to Webcast Presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
8. TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast
9. Quest Diagnostics Announces Annual Shareholders Meeting Webcast
10. Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
11. Exelixis Announces May 13 Webcast of Presentation at the Bank of America Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Drug Discovery Services portfolio to include an array of biochemical analyses critical ... reliable data to drive their hit-to-lead and SAR programs, including inhibitor potency and ...
(Date:2/23/2017)... 23, 2017  In Atlanta, it seems everyone has a ... intertwine to create an expressive and dynamic community unlike any ... and contribute to it. With their newest ... seeks to carry on that tradition with a unique, ... salon is the newest of 13 nationwide locations, ...
(Date:2/23/2017)... San Antonio, TX (PRWEB) , ... February 23, ... ... and Drug Administration (FDA) de novo clearance to begin marketing the SPEAC® System, ... is indicated for adults at home or in healthcare facilities during periods of ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... studies (such as insulin, cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or ... Salivary Insulin Assay from Salimetrics’ SalivaLab , the relationship between insulin and ...
Breaking Biology Technology:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/13/2017)... WASHINGTON , Feb. 13, 2017 Former ... U.S. Senate Judiciary Committee, Janice Kephart of ... regarding President Donald Trump,s "Executive Order: Protecting ... States" (Jan. 27, 2017):  "As President Trump,s ... 9th Circuit has now essentially banned the travel ban, ...
(Date:2/9/2017)... 2017 The biomass boiler market report by ... boiler market globally in terms of revenue (US$ Mn) ... market for biomass boilers has been segmented on the ... country/region. The market based on feedstock type, has been ... & energy crops, urban residues, and others. On the ...
Breaking Biology News(10 mins):